Ophthotech Corporation Reports First Quarter 2014 Financial Results And Provides Business Update

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ophthotech Corporation (Nasdaq:OPHT) today announced financial results for the first quarter ended March 31, 2014 and provided an update on the Company’s business including its product development programs.

Review of First Quarter Accomplishments

•In January 2014, the Company reached an enrollment milestone resulting in a second tranche payment of $41.7 million to the Company under its $125.0 million royalty financing agreement with Novo A/S.

Help employers find you! Check out all the jobs and post your resume.

Back to news